Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa
The Lancet HIV in conversation with - En podkast av The Lancet Group
Kategorier:
Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa. Read the full article: Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPT...
